Elliot Wilbur

The ruling by the U.S. Supreme Court to overturn Roe v. Wade and leave the decision of abortion to the states has been a big topic over the last few days. An analyst singles out a pharmaceutical company that could benefit from increased purchases of over-the-counter contraceptives. The Perrigo...

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) reported fourth-quarter sales and revenues that slightly exceeded estimates but issued a guarded outlook for 2020. The Teva Analysts BofA Securities analyst Jason Gerberry reiterated an Underperform rating on Teva and raised the price target from $8...

Flexion Therapeutics Inc (NASDAQ: FLXN) shares are on a tear after the FDA approved an update this week of the product label for its osteoarthritis pain drug Zilretta, which was originally approved in October 2017.  The Flexion Analysts Needham analyst Serge Belanger maintained a Buy...

Allergan plc (NYSE: AGN) was in for a disappointment with its investigational depression drug candidate Rapastinel, one day after Johnson & Johnson (NYSE: JNJ) secured FDA approval for its treatment-resistant depression drug esketamine. The Analysts Wells Fargo Securities analyst David Maris...

PLx Pharma Inc (NASDAQ: PLXP) recently raised $15 million in gross proceeds by issuing convertible preferred stock financing. The capital raise is significantly more dilutive than was previously anticipated, which indicates that future fundraising for a successful Vazalore launch may be...

Flexion Therapeutics Inc (NASDAQ: FLXN) is scheduled to report preliminary fourth-quarter Zilretta sales results and initial 2019 guidance. This will nudge expectations toward reality, as the current consensus estimates for Zilretta sales appear too aggressive, according to Raymond James...

Adamis Pharmaceuticals Corp (NASDAQ: ADMP) announced its NDA filing Friday for a fast-dissolving sublingual tadalafil tablet for erectile dysfunction. The Analyst Raymond James analyst Elliot Wilbur maintained an Outperform on Adamis. The Thesis The submission of the NDA is positive, as...

Lannett Company, Inc. (NYSE: LCI) announced the amendment of its Senior Secured Credit Facility Term A loan of $275 million, which takes the company a step closer to emerging from debt following the loss of generic levothyroxine, according to Raymond James. The Analyst Analyst Elliot Wilbur...

Raymond James downgraded Mallinckrodt Public Limited Company (NYSE: MNK) on valuation after the drugmaker's second-quarter report.  The Analyst Raymond James analyst Elliot Wilbur downgraded Mallinckrodt from Outperform to Market Perform. The Thesis The Q2 print demonstrates Mallinckrodt...